Afsaneh Jahani
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Afsaneh Jahani has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
- Nafiseh Jirofti
Orthopedic Research Center, Department of Orthopedic Surgery, Mashhad University of Medical Sciences, Mashhad, Iran
6 shared publications - Ali Moradi
Orthopedic Research Center, Department of Orthopedic Surgery, Mashhad University of Medical Sciences, Mashhad, Iran
5 shared publications - Davod Mohebbi-Kalhori
Chemical Engineering Department, University of Sistan and Baluchestan, Zahedan, Iran
2 shared publications - Farkhonde Sarhaddi
Department of Pathology, School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran; Faculty of medical science, Zahedan Branch, Islamic Azad University, Zahedan, Iran
2 shared publications - Fatemeh Kalalinia
Department of Pharmaceutical Biotechnology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran
2 shared publications - Gholam Hosein Kazemzadeh
Vascular and Endovascular Surgery Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
2 shared publications
Latest Publications
- 27 September 2026
- Published by Springer Nature in Journal of Polymers and the Environment
- Vol. 34 (10) , 261
Crocin-Loaded 3D-Printed Chitosan/Collagen/nano-Hydroxyapatite Scaffolds for Rabbit Calvarial Defect Repair: In Vitro and In Vivo Evaluation
- 27 September 2026
- Published by Springer Nature in Journal of Polymers and the Environment
- Vol. 34 (10) , 261
Crocin-Loaded 3D-Printed Chitosan/Collagen/nano-Hydroxyapatite Scaffolds for Rabbit Calvarial Defect Repair: In Vitro and In Vivo Evaluation
- Open Access
- 4 November 2025
- Published by Springer Nature in Journal of Materials Science: Materials in Medicine
- Vol. 36 (1) , 1-15
Development of a novel small diameter vascular graft based on an electrospun blend PET/PU scaffold: from fabrication to structural, mechanical, and in vitro evaluation
The development of small-diameter vascular grafts (SDVGs) remains a significant challenge and unsolved problem due to issues with compliance mismatch, thrombosis, and graft failure. This study explores electrospun blended scaffolds made from polyethylene terephthalate (PET) and polyurethane (PU), both Food and Drug Administration (FDA)-approved polymers, as potential candidates for small-diameter vascular applications. Nanofibrous scaffolds composed of blended PET and PU were fabricated using the electrospinning method. The morphological and chemical properties of the scaffolds were characterized by FE-SEM, porosity measurement, FTIR, and DSC. Comprehensive mechanical evaluations, including tensile strength, burst pressure, and compliance, were performed. Biocompatibility was assessed by examining cellular adhesion, proliferation, and viability on the scaffolds. For in vivo evaluation, the electrospun scaffolds were subcutaneously implanted in rats. The PET/PU blended scaffolds exhibited excellent physicochemical compatibility, with mechanical properties within the range of native small-diameter blood vessels (SDBVs). Burst pressure and compliance evaluations demonstrated the ability of the PET/PU blend to mitigate the compliance mismatch commonly observed in synthetic grafts. Additionally, the scaffolds supported strong human cell adhesion, proliferation, and high cell viability, indicating good biocompatibility. No signs of necrosis, calcification, severe fibrosis, inflammation, or foreign body granulomatous reaction were observed following subcutaneous implantation of the scaffolds. Electrospun PET/PU scaffolds offer promising mechanical and biocompatible properties for SDVGs applications. The ability to address compliance mismatch, combined with excellent cellular support, positions these scaffolds as a strong candidate for clinical use. However, further preclinical and clinical studies are necessary to validate their long-term safety, performance, and commercial viability.
- 4 November 2025
- Published by Springer Nature in Journal of Materials Science: Materials in Medicine
- Vol. 36 (1) , 1-15
Open AccessDevelopment of a novel small diameter vascular graft based on an electrospun blend PET/PU scaffold: from fabrication to structural, mechanical, and in vitro evaluation
The development of small-diameter vascular grafts (SDVGs) remains a significant challenge and unsolved problem due to issues with compliance mismatch, thrombosis, and graft failure. This study explores electrospun blended scaffolds made from polyethylene terephthalate (PET) and polyurethane (PU), both Food and Drug Administration (FDA)-approved polymers, as potential candidates for small-diameter vascular applications. Nanofibrous scaffolds composed of blended PET and PU were fabricated using the electrospinning method. The morphological and chemical properties of the scaffolds were characterized by FE-SEM, porosity measurement, FTIR, and DSC. Comprehensive mechanical evaluations, including tensile strength, burst pressure, and compliance, were performed. Biocompatibility was assessed by examining cellular adhesion, proliferation, and viability on the scaffolds. For in vivo evaluation, the electrospun scaffolds were subcutaneously implanted in rats. The PET/PU blended scaffolds exhibited excellent physicochemical compatibility, with mechanical properties within the range of native small-diameter blood vessels (SDBVs). Burst pressure and compliance evaluations demonstrated the ability of the PET/PU blend to mitigate the compliance mismatch commonly observed in synthetic grafts. Additionally, the scaffolds supported strong human cell adhesion, proliferation, and high cell viability, indicating good biocompatibility. No signs of necrosis, calcification, severe fibrosis, inflammation, or foreign body granulomatous reaction were observed following subcutaneous implantation of the scaffolds. Electrospun PET/PU scaffolds offer promising mechanical and biocompatible properties for SDVGs applications. The ability to address compliance mismatch, combined with excellent cellular support, positions these scaffolds as a strong candidate for clinical use. However, further preclinical and clinical studies are necessary to validate their long-term safety, performance, and commercial viability.
- Open Access
- 30 September 2025
- Published by Springer Nature in Knee Surgery & Related Research
- Vol. 37 (1) , 1-15
Clinical outcomes of artificial meniscus scaffolds for partial meniscus injury: a systematic review and meta-analysis
Background: Meniscal injuries, involving damage to the critical fibrocartilaginous structure of the knee joint, often necessitate surgical intervention, including meniscal allograft transplantation or the use of commercial implants. Despite advances in implant based therapies, there is no consensus regarding the comparative efficacy of collagen meniscus implants (CMI) versus polyurethane-based (PU-based) scaffolds. This review aimed to systematically evaluate and compare the clinical outcomes associated with these two implant types for partial meniscal repair. Methods: A comprehensive systematic review was conducted to evaluate the clinical outcomes of meniscal implants by searching multiple databases including Medline/PubMed, Web of Science, Embase, Scopus, and Cochrane in the temporal range of 1999–2024. The review focused on pre–post studies and assessed various patient-reported outcome measures, including the visual analog scale (VAS), international Knee Documentation Committee (IKDC), Lysholm, knee injury and osteoarthritis outcome score (KOOS), as well as the Tegner activity score. These outcomes were evaluated across different follow-up periods [short-term (6 month to 2.5 years), mid-term (2.5–5 years) and long-term (10 years)] following meniscal implant implantation. A random-effects meta-analysis model was used to address heterogeneity, along with a sensitivity analysis to evaluate the robustness of pooled estimates. The National Institutes of Health (NIH) quality assessment tool was utilized to assess the methodological quality in the studies. Results: The meta-analysis identified 26 studies that met the inclusion criteria, and the overall quality of the included studies was mostly fair to good. The analysis showed that both CMI and PU-based scaffolds improved clinical outcomes in patients with partial meniscus injuries, with the implants evaluated across short-term, mid-term, and long-term follow-up periods. Specifically, the analysis found: the VAS scores significantly improved during the short-term follow-up by an average of −1.86 points for CMI and −1.98 points for PU-based scaffolds. Lysholm scores significantly improved at short-term follow-up, increasing by an average of 29.26 points for CMI and 24.98 points for PU-based scaffolds. For the Tegner score, CMI implants showed an average increase of 2.02 points in the short-term, while PU-based implants exhibited a negligible change of −0.05 points. Conclusions: Both CMI and PU-based scaffolds demonstrated improved clinical outcomes, but showed some differences in effectiveness over follow-up periods. PU-based scaffolds offer faster integration and short-term effectiveness, while CMI promotes gradual tissue regeneration and long-term stability. Although these differing characteristics support personalized meniscal repair strategies, the lack of comparative studies limits definitive clinical guidance. Level of evidence: Level III, IV.
- 30 September 2025
- Published by Springer Nature in Knee Surgery & Related Research
- Vol. 37 (1) , 1-15
Open AccessClinical outcomes of artificial meniscus scaffolds for partial meniscus injury: a systematic review and meta-analysis
Background: Meniscal injuries, involving damage to the critical fibrocartilaginous structure of the knee joint, often necessitate surgical intervention, including meniscal allograft transplantation or the use of commercial implants. Despite advances in implant based therapies, there is no consensus regarding the comparative efficacy of collagen meniscus implants (CMI) versus polyurethane-based (PU-based) scaffolds. This review aimed to systematically evaluate and compare the clinical outcomes associated with these two implant types for partial meniscal repair. Methods: A comprehensive systematic review was conducted to evaluate the clinical outcomes of meniscal implants by searching multiple databases including Medline/PubMed, Web of Science, Embase, Scopus, and Cochrane in the temporal range of 1999–2024. The review focused on pre–post studies and assessed various patient-reported outcome measures, including the visual analog scale (VAS), international Knee Documentation Committee (IKDC), Lysholm, knee injury and osteoarthritis outcome score (KOOS), as well as the Tegner activity score. These outcomes were evaluated across different follow-up periods [short-term (6 month to 2.5 years), mid-term (2.5–5 years) and long-term (10 years)] following meniscal implant implantation. A random-effects meta-analysis model was used to address heterogeneity, along with a sensitivity analysis to evaluate the robustness of pooled estimates. The National Institutes of Health (NIH) quality assessment tool was utilized to assess the methodological quality in the studies. Results: The meta-analysis identified 26 studies that met the inclusion criteria, and the overall quality of the included studies was mostly fair to good. The analysis showed that both CMI and PU-based scaffolds improved clinical outcomes in patients with partial meniscus injuries, with the implants evaluated across short-term, mid-term, and long-term follow-up periods. Specifically, the analysis found: the VAS scores significantly improved during the short-term follow-up by an average of −1.86 points for CMI and −1.98 points for PU-based scaffolds. Lysholm scores significantly improved at short-term follow-up, increasing by an average of 29.26 points for CMI and 24.98 points for PU-based scaffolds. For the Tegner score, CMI implants showed an average increase of 2.02 points in the short-term, while PU-based implants exhibited a negligible change of −0.05 points. Conclusions: Both CMI and PU-based scaffolds demonstrated improved clinical outcomes, but showed some differences in effectiveness over follow-up periods. PU-based scaffolds offer faster integration and short-term effectiveness, while CMI promotes gradual tissue regeneration and long-term stability. Although these differing characteristics support personalized meniscal repair strategies, the lack of comparative studies limits definitive clinical guidance. Level of evidence: Level III, IV.
- 16 July 2025
- Published by Elsevier in Materials Science and Engineering: C
- Vol. 177, 214416
Exploring bioactive bone cement pastes: A promising solution for orthopedic surgeries
- 16 July 2025
- Published by Elsevier in Materials Science and Engineering: C
- Vol. 177, 214416
Exploring bioactive bone cement pastes: A promising solution for orthopedic surgeries
- Open Access
- 25 March 2025
- Published by Elsevier in Journal of Tissue Viability
- Vol. 34 (3) , 100888
Assessment of the structural and histopathological challenges of binary electrospun PET-based nanofibers for tissue engineering applications
- 25 March 2025
- Published by Elsevier in Journal of Tissue Viability
- Vol. 34 (3) , 100888
Open AccessAssessment of the structural and histopathological challenges of binary electrospun PET-based nanofibers for tissue engineering applications
- 6 March 2025
- Published by World Scientific Pub Co Pte Ltd in Nano LIFE
- Vol. 16 (02)
Development and Characterization of Polymer-stabilized Dobutamine Nanomicelles for Improved Drug Delivery
Dobutamine (Dobu) is a widely utilized therapeutic agent for heart failure with emerging potential in oncology. However, its clinical application is constrained by rapid release, short half-life and associated toxicity. This study introduces a dual-polymer nanomicelle system employing Pluronic F127 and lignin to encapsulate Dobu, aiming to enhance its release profile, minimize cytotoxicity and improve therapeutic efficacy. Nanomicelles were synthesized using an oil-in-water emulsion method, achieving encapsulation efficiencies of 99% for F127 and 80% for lignin, along with a controlled drug release profile. This novel dual-polymer nanomicelle system achieves high encapsulation efficiency (99% for F127 versus 80% for lignin) and controlled release, significantly reducing the burst release observed with free Dobutamine. Release studies demonstrated that F127 and lignin nanomicelles significantly reduced burst release compared to free Dobu, extending release durations up to 7 h. Cytotoxicity assays using NIH/3T3 fibroblast cells revealed increased cell viability for encapsulated Dobu, with F127 nanomicelles showing superior biocompatibility. Additionally, in vitro antibacterial evaluations confirmed that the nanomicelles did not inhibit microbial growth, highlighting their suitability for sterile applications. These findings suggest that F127 and lignin-based nanomicelles provide a promising platform for safer, controlled Dobu delivery in cardiovascular and oncological therapies.
- 6 March 2025
- Published by World Scientific Pub Co Pte Ltd in Nano LIFE
- Vol. 16 (02)
Development and Characterization of Polymer-stabilized Dobutamine Nanomicelles for Improved Drug Delivery
Dobutamine (Dobu) is a widely utilized therapeutic agent for heart failure with emerging potential in oncology. However, its clinical application is constrained by rapid release, short half-life and associated toxicity. This study introduces a dual-polymer nanomicelle system employing Pluronic F127 and lignin to encapsulate Dobu, aiming to enhance its release profile, minimize cytotoxicity and improve therapeutic efficacy. Nanomicelles were synthesized using an oil-in-water emulsion method, achieving encapsulation efficiencies of 99% for F127 and 80% for lignin, along with a controlled drug release profile. This novel dual-polymer nanomicelle system achieves high encapsulation efficiency (99% for F127 versus 80% for lignin) and controlled release, significantly reducing the burst release observed with free Dobutamine. Release studies demonstrated that F127 and lignin nanomicelles significantly reduced burst release compared to free Dobu, extending release durations up to 7 h. Cytotoxicity assays using NIH/3T3 fibroblast cells revealed increased cell viability for encapsulated Dobu, with F127 nanomicelles showing superior biocompatibility. Additionally, in vitro antibacterial evaluations confirmed that the nanomicelles did not inhibit microbial growth, highlighting their suitability for sterile applications. These findings suggest that F127 and lignin-based nanomicelles provide a promising platform for safer, controlled Dobu delivery in cardiovascular and oncological therapies.
- Open Access
- 1 September 2024
- Vol. 12 (9) , 622-630
Calculation of the Forearm and Hand Three-Dimensional Anthropometry Based on Two-Dimensional Image Feature Extraction: An Approach for Cock-up Splint Design
Objectives: An alternative to both the time-consuming traditional and the expensive three-dimensional (3D) methods for splint design is to use two-dimensional (2D) images. The present study utilized image processing to achieve an automatic and practical method of anthropometry measurement to design and build a personalized and remote cock-up splint. This method is applicable for patients unable to personally attend clinic appointments. Methods: The defined landmarks of the cock-up splint of 100 adult participants were measured manually. Each individual had a 2D image taken of their upper limb using a customized imaging device. The 2D image portions that corresponded to the manual measurements were then identified, and their sizes were retrieved in pixels using MATLAB software. To find equations between manual 3D measurements and 2D image processing ones, multiple linear regression analysis was performed on landmark variables. Results: We were able to determine equations to estimate manual dimensions based on 2D image data. In the men's group, we could predict the third finger length, forearm circumference at three levels, and the largest forearm circumference. In the women's group, in addition to variables predicted for men, hand circumference at the distal palmar crease and first web levels, as well as arm circumference, could be predicted using the identified equations. Conclusion: Based on the findings, 2D image processing could bean appropriate method for designing personalized cock-up splints.
- 1 September 2024
- Vol. 12 (9) , 622-630
Open AccessCalculation of the Forearm and Hand Three-Dimensional Anthropometry Based on Two-Dimensional Image Feature Extraction: An Approach for Cock-up Splint Design
Objectives: An alternative to both the time-consuming traditional and the expensive three-dimensional (3D) methods for splint design is to use two-dimensional (2D) images. The present study utilized image processing to achieve an automatic and practical method of anthropometry measurement to design and build a personalized and remote cock-up splint. This method is applicable for patients unable to personally attend clinic appointments. Methods: The defined landmarks of the cock-up splint of 100 adult participants were measured manually. Each individual had a 2D image taken of their upper limb using a customized imaging device. The 2D image portions that corresponded to the manual measurements were then identified, and their sizes were retrieved in pixels using MATLAB software. To find equations between manual 3D measurements and 2D image processing ones, multiple linear regression analysis was performed on landmark variables. Results: We were able to determine equations to estimate manual dimensions based on 2D image data. In the men's group, we could predict the third finger length, forearm circumference at three levels, and the largest forearm circumference. In the women's group, in addition to variables predicted for men, hand circumference at the distal palmar crease and first web levels, as well as arm circumference, could be predicted using the identified equations. Conclusion: Based on the findings, 2D image processing could bean appropriate method for designing personalized cock-up splints.